Skip to main content
ASTRO 2024 Main banner
Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis
Back

Jeffrey Wong, MD, FASTRO

City of Hope National Medical Center
Duarte, CA

Jeffrey Wong MD, FASTRO is Professor in the Department of Radiation Oncology at City of Hope in Duarte, California. His primary areas of interest are in the development of novel strategies and agents for image-guided and biologically targeted radiation therapy for patients with local regional and systemic disease. He is focused on the development and use of targeted radiopharmaceuticals for therapy, imaging and image guided radiotherapy. His other area of research is in the development, clinical evaluation and adoption of image guided IMRT targeted total marrow irradiation (TMI) and total marrow and lymphoid irradiation (TMLI), a form of organ sparing total body irradiation in patients undergoing hematopoietic cell transplantation.

Disclosures:

  • Employment: City of Hope Medical Group:Physician:Employee
  • Compensation: Telix Inc.: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: present ;Reflexion, Inc.: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Honoraria-End Date: present ;Blue Earth Diagnostic: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;Accuray, Inc.: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;Varian/Siemens: Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Honoraria-End Date: present ;Fusion, Inc: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;Imaginab: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;Janssen: Rese
  • Ownership: none
  • Leadership: none

Presentation(s):